Abstract
There are various drugs which are used to improve functions of the brain disturbed by stroke or senile dementia of Alzheimer type (SDAT) in Japan. Usually they are divided into two groups by the different mechanisms of action (Otomo, 1989). One group acts mainly on the vascular system of the brain; i.e., increasing blood flow of the brain, promoting antiplatelet coagulation or lowering blood viscosity. The drugs in this group are nicardipine, ifenprodil, pentoxifylline, dilazep, trapidil, vinpocetine, moxisylate, brovincamine, nicergoline and cinepazide. The other group acts directly on the brain; i.e., as neurotransmitters or activators of energy metabolism. These include dihydroergotoxine, Ca hopantenate, idebenone, bifemelane, amantadine, tiapride and indeloxazine.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Araga S, Nishikawa K, Fukuda C et al (1989): Effect of bifemelane hydrochloride on patients with cerebrovascular disorders and Alzheimer’s disease. Shinryo and Shinyaku 26:747–758.
Gottfries CG, Brane G, Gullberg B and Steen G (1982): A new rating scale for dementia syndromes. Arch Gerontol Geriatr 1:311–330.
Hagino N (1991): Basic concept of an application of TJ-23 for the treatment of Alzheimer’s disease. In: Kampo and Brain Function, Hagino N, Yoshida M and Hasegawa K, eds. Tokyo: Medical Journal Press, pp. 57–69.
Kawajiri S, Taniguchi K, Sakurai T, Kojima H and Yamasaki T (1990): Effect of DM 9384 on extracellular acetylcholine in the rat frontal cortex measured with microdialysis. Xlth Int Cong Pharmacol Abstr p. 278.
Kinoshita A, Yamada K, Hayakawa T et al (1990): Effect of bifemelane on cultured septal neurons. Igakuno ayumi 4:257–258.
Kojima H, Kawajiri S, Sakurai T and Yamasaki T (1991): Effect of DM 9384, a new pyrrolidone derivative, on passive avoidance and cerebral choline acetyltransferase activity in rats. In: Basic, Clinical and Therapeutic Aspects of Alzheimer’s and Parkinson’s Diseases, Nagatsu T, Fisher A and Yoshida M, eds. New York: Plenum Press, pp. 367.
Mizushima N (1991): Action of TJ-23 on SDAT patients. In: Kampo and Brain Function, Hagino N, Yoshida M and Hasegawa K, eds. Tokyo: Medical Journal Press, pp. 137–142.
Ogawa N, Haba K, Yoshikawa H et al (1988a): Comparison of the effects of befemelane hydrochloride, idebenone and indeloxazine hydrochloride on ischmia-induced depletion of brain acetylcholine levels in gerbils. Res Commun Chem Pathol Pharmacol 61:285–288.
Ogawa N, Mizukawa K, Ono T et al (1988b): Improvement of mACh.lm receptors of aged rats by bifemelane hydrochloride. Geriat Med 26:1915–1920.
Ohara K, Ohara K, Kawaguchi H et al (1989): Effect of bifemelane hydrochloride on patients with cerebrovascular disorders and senile dementia. Geriat Med 27:1525–1535.
Otomo E (1989): Brain blood circulation and brain metabolism activators. Gendaiiryo 5:53–57.
Pearson RCA, Esiri MM, Hiorns RW et al (1985): Anatomical correlates of the distributions of the pathological changes in the neocortex in Alzheimer disease. Proc Natl Acad Sci USA 82:4531–4534.
Takemasa K and Koga Y (1990): Effect of bifemelane hydrochloride on patients with vascular dementia. Shinyaku and Rinsho 39:191–202.
Wilcock GK and Esiri MM (1982): Plaques, tangles and dementia. J Neurol Sci 56:343–356.
Yamamoto T (1991): Kampo therapy of patients with senile dementia of Alzheimer type. In: Kampo and Brain Function, Hagino N, Yoshida M and Hasegawa K, eds. Tokyo: Medical Journal Press, pp. 129–136.
Yoshida M (1991): Effect of TJ-23 on the ChAT activitv of the rat frontal cortex. In: Kampo and Brain Function, Hagino N, Yoshida M and Hasegawa K, eds. Tokyo: Medical Journal Press, pp. 41–51.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Yoshida, M. (1991). Alzheimer Therapy with Cholinomimetics: The Japanese Experience. In: Becker, R., Giacobini, E. (eds) Cholinergic Basis for Alzheimer Therapy. Advances in Alzheimer Disease Therapy. Birkhäuser, Boston, MA. https://doi.org/10.1007/978-1-4899-6738-1_36
Download citation
DOI: https://doi.org/10.1007/978-1-4899-6738-1_36
Publisher Name: Birkhäuser, Boston, MA
Print ISBN: 978-1-4899-6740-4
Online ISBN: 978-1-4899-6738-1
eBook Packages: Springer Book Archive